MERS-CoV vaccine (Ludwig-Maximilians-University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMERS-CoV vaccine (Ludwig-Maximilians-University)
Drug Alias NameMiddle East respiratory syndrome coronavirus vaccine - IDT Biologika GmbH/Ludwig-Maximilians-UniversityMVA-MERS-S
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLudwig-Maximilians-University
China Registration ClassN/A

Develop Information

Active CompaniesLudwig-Maximilians-University
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A